Work with Mercuriosity

Diagnosis first. Treatment second.

Every engagement follows the same order you would expect in a clinic. First establish where your story loses trust. Then repair it, in the order that moves your next round or your next KOL conversation most. The method comes from inside MedTech, it carried the EIT implants to a Johnson and Johnson acquisition and Cresco Spine to FDA clearance.

Three ways in, matched to how much of the work you want to do yourself. Self-guided, diagnosed for you, or repaired with you.

Self-guided · Digital kit

The Founder Signal Kit

EUR 349 excl. VAT

For the founder who wants to build their own signal. The kit turns the Founder Signal method into a protocol you can run without me.

  • Your founder positioning line, built from a fill-in framework
  • The three-layer profile structure investors actually read: now, proof, point of view
  • Content angles for orthopedics, spine and neurosurgery audiences
  • A ninety-day visibility plan with a realistic weekly cadence
  • Claim ceilings that keep every post inside Medical Device Regulation (MDR) boundaries
See the full Founder Signal Kit

Diagnosis · delivered in 10 working days

The Congruence Audit

EUR 1,950 excl. VAT

You send four things: your deck, your website, your regulatory narrative and your founder profile. I read them the way an investor, a surgeon and a Notified Body will.

  • A scored Congruence Report across all four surfaces, every gap named
  • Each gap paired with its specific repair, prioritized into a ninety-day roadmap
  • A claim-ceiling review: which of your claims survive a skeptical KOL and MDR Article 7
  • Your Evidence Chain, drafted: one chain, translated for investor, surgeon and regulator
  • A sixty-minute debrief to walk the findings and agree what to fix first
See the full Congruence Audit

Fixed price, fixed scope. Expand it into the complete Foundation Gate within 30 days and your total diagnostic fee stays capped at EUR 2,750. Incongruence rarely announces itself. It shows up as a rejected term sheet or a KOL who quietly loses interest.

Diagnosis then treatment · Gate, 4-week build, 90 days · Done with you

The Medtech Founder Signal System

EUR 2,750 gate · EUR 8,000 build

A diagnostic, positioning, output and implementation system for early orthopaedic and neuro-implant founders. Align your evidence, founder authority and stakeholder messaging on congruency before you increase visibility.

  • The Foundation Gate first: a Product Viability Scan and a Congruence Audit, ending in go, conditional go or no-go
  • Your Need-to-Have Evidence and Stakeholder Value Map, translated for KOLs, hospital and investors
  • Your Founder Authority Blueprint: positioning line, point of view, core bio and voice
  • Your LinkedIn profile, company page, website and deck repaired onto one core value
  • Five tailored KOL Conversation Pathways and your first four content pieces
  • The personalized Founder Content Engine, transferred at activation
  • Ninety days of implementation with a weekly 30-minute session, a day-45 correction and a day-90 Founder Signal Scoreboard
See the full Founder Signal System

Complete trajectory EUR 10,750 excl. VAT across approximately 19 calendar weeks. Phase 2 is only quoted after a go. One founder at a time through the build, by someone who built company signal at EIT, Cresco Spine and Atraxon Biotech.

Not sure where to start

Start with the free diagnostics. The Congruence Gap Scan shows you where your story loses trust in about ten minutes. If the gaps cluster, the Audit maps them precisely. If the whole story needs rebuilding and proving, the Foundation Gate decides whether the System is the right next step.

Run the free Congruence Gap Scan

The method is not theoretical. The spinal implants Nancy Lamerigts, MD PhD, designed at EIT are sold today by DePuy Synthes as Conduit. Cresco Spine is FDA cleared and launching globally in 2026. Atraxon Biotech applies the same method in a different clinical field. Mercuriosity transfers that operating logic to pre-market founders in orthopedics, spine and neurosurgery.